Anne Marie McNeill, MD
MOHS-Micrographic Surgery · Newport Beach, CANPI 1841365970
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,565 of the $7,007 with a category attached, or 65.1%. 22 manufacturers reported payments, led by AbbVie at 41.6% of the total. Reporting peaked in 2021 at $1,883 and has fallen 84.9% since, to $284 in 2025.
Across 133 payments — averaging $52.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Merz North America, Inc.$2K
- Galderma Laboratories, L.p.$235
- Regeneron Healthcare Solutions, Inc.$187
- Revance Therapeutics, Inc.$178
- Amgen$172
- plus $1K from 16 others
What the payments were for
- Consulting fees$1,00014%
- Speaking & faculty fees$1,44221%
- Food & beverage$4,56565%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 38 | $2,918 |
| Merz North America, Inc. | 17 | $2,291 |
| Galderma Laboratories, L.p. | 14 | $235 |
| Regeneron Healthcare Solutions, Inc. | 7 | $187 |
| Revance Therapeutics, Inc. | 5 | $178 |
| Amgen | 7 | $172 |
| Sanofi | 5 | $164 |
| Incyte Corporation | 5 | $128 |
| Sun Pharmaceutical Industries Inc. | 6 | $120 |
| Novartis | 5 | $111 |
| LEO Pharma Inc. | 3 | $86 |
| Mayne Pharma Commercial LLC | 3 | $68 |
| Biofrontera Inc. | 5 | $66 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $49 |
| DUSA Pharmaceuticals, Inc. | 2 | $46 |
| Bard Peripheral Vascular, Inc. | 2 | $42 |
| VYNE Pharmaceuticals Inc. | 1 | $39 |
| Boston Scientific | 1 | $29 |
| Arcutis Biotherapeutics, Inc. | 1 | $24 |
| Bristol Myers Squibb | 1 | $20 |
| Strata Skin Sciences, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,007 in reported general payments places this provider in the 80th percentile of 144 mohs-micrographic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 43 | $817 |
| Fluocinonide | 18 | $560 |
| Tacrolimus | 15 | $536 |
| Mupirocin | 20 | $127 |
| Minoxidil | 21 | $99 |
| Fluconazole | 11 | $53 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Newport Beach
- Grace LiuNewport Beach$10K
- Adam RotundaNewport Beach$8K
- Hung OngNewport Beach$4K
- Gregory HendersonNewport Beach$4K
- Sarah ArronBurlingame$98K
- Daniel Zelacla Jolla$43K
- Ralph MasseySanta Monica$38K
- Michael MortazieOrange$29K
- Sumaira AasiStanford$27K
- Andrea WilleySacramento$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.